Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

F0260000

Fluphenazine decanoate

European Pharmacopoeia (EP) Reference Standard

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C32H44F3N3O2S
Número de CAS:
5002-47-1
Peso molecular:
591.77
Número CE:
225-672-4
Número MDL:
MFCD00798504
Código UNSPSC:
41116107
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

fluphenazine

fabricante / nombre comercial

EDQM

aplicaciones

pharmaceutical (small molecule)

Formato

neat

cadena SMILES

FC(F)(F)c1cc2c(cc1)Sc3c(cccc3)N2CCCN4CCN(CC4)CCOC(=O)CCCCCCCCC

InChI

1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3

Clave InChI

VIQCGTZFEYDQMR-UHFFFAOYSA-N

Categorías relacionadas

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Fluphenazine decanoate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Envase

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

Y0000009

Fluphenazine enantate, European Pharmacopoeia (EP) Reference Standard

Y0000298

Fluphenazine octanoate, European Pharmacopoeia (EP) Reference Standard

Y0000299

Fluphenazine sulfoxide, European Pharmacopoeia (EP) Reference Standard

Y0000708

Fluphenazine impurity mixture, European Pharmacopoeia (EP) Reference Standard

F0280000

Fluphenazine dihydrochloride, European Pharmacopoeia (EP) Reference Standard

1282004

Fluphenazine hydrochloride, United States Pharmacopeia (USP) Reference Standard

1280803

Fluphenazine decanoate dihydrochloride, United States Pharmacopeia (USP) Reference Standard

1281001

Fluphenazine enanthate dihydrochloride, United States Pharmacopeia (USP) Reference Standard

PHR1792

Fluphenazine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

BP167

Fluphenazine hydrochloride, British Pharmacopoeia (BP) Reference Standard

1282026

Fluphenazine Related Compound B, United States Pharmacopeia (USP) Reference Standard

Pictogramas

Skull and crossbonesHealth hazard
GHS06,GHS08

Palabra de señalización

Danger

Frases de peligro

H300,H361

Clasificaciones de peligro

Acute Tox. 2 Oral - Repr. 2

Código de clase de almacenamiento

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

Clase de riesgo para el agua (WGK)

WGK 3

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Who receives long-acting antipsychotic medications?
William M Glazer
Psychiatric services (Washington, D.C.), 58(4), 437-437 (2007-04-07)
Branimir Margetić et al.
Psychiatria Danubina, 17(1-2), 94-96 (2006-01-07)
We describe the case of a 39-year-old patient with schizophrenia who developed worsening of glucose metabolism during treatment with two different atypical antipsychotics, clozapine and quetiapine. Diabetes mellitus was recognized during clozapine treatment. During quetiapine treatment, while patient was taking
Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
Trino Baptista et al.
Schizophrenia research, 89(1-3), 350-352 (2006-10-13)
Switching as only temporal solution for patients with antipsychotic-associated diabetes: further observations.
Branimir Margetić et al.
Psychiatria Danubina, 19(1-2), 87-88 (2007-07-03)
Ayman Allahham et al.
International journal of pharmaceutics, 270(1-2), 139-148 (2004-01-17)
A micro-capillary rheometer consisted of a fine needle with an internal diameter of 347 microm attached to a 1 ml removable-needle syringe within an Instron device that operated in compression mode to provide various crosshead speeds ranging from 150 to
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico